Brief: Aquestive Therapeutics Licenses Sympazan® (Clobazam) Oral Film To Assertio Holdings, Inc.
27/10/2022 14:52
Oct 27 (Reuters) - Aquestive Therapeutics Inc AQST.O :
* AQUESTIVE THERAPEUTICS LICENSES SYMPAZAN® (CLOBAZAM) ORAL
FILM
TO ASSERTIO HOLDINGS, INC.
Source text for Eikon: ID:nGNX5TTs0m
Further company coverage: AQST.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aquestive Therapeutics
See all newsBrief: Aquestive Therapeutics Inc - Enters Five-Year Term Loan Facility Of Up To $150 Million On May 12, 2026 - SEC Filing
Aquestive Therapeutics Q1 revenue jumps on higher license and royalty income
Brief: Aquestive Therapeutics Announces Completion Of Type A Meeting With FDA For Anaphylm™ (Dibutepinephrine) Sublingual Film
Aquestive misses Q4 revenue estimates, EBITDA loss widens
Brief: Aquestive Therapeutics, Inc. Q4 Net Income USD -31.86 Million